The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(R)-N-(4-(1-(7-(hydroxyamino)-7-oxoheptyl)-4-morpholino-1H-pyrazolo[3,4-d]pyrimidin-6-yl)phenyl)-2-methylmorpholine-4-carboxamide ID: ALA4532398
Cas Number: 2271413-06-8
PubChem CID: 137628684
Product Number: H647174, Order Now?
Max Phase: Preclinical
Molecular Formula: C28H38N8O5
Molecular Weight: 566.66
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: C[C@@H]1CN(C(=O)Nc2ccc(-c3nc(N4CCOCC4)c4cnn(CCCCCCC(=O)NO)c4n3)cc2)CCO1
Standard InChI: InChI=1S/C28H38N8O5/c1-20-19-35(14-17-41-20)28(38)30-22-9-7-21(8-10-22)25-31-26(34-12-15-40-16-13-34)23-18-29-36(27(23)32-25)11-5-3-2-4-6-24(37)33-39/h7-10,18,20,39H,2-6,11-17,19H2,1H3,(H,30,38)(H,33,37)/t20-/m1/s1
Standard InChI Key: YPXRCUVTZDXVHY-HXUWFJFHSA-N
Molfile:
RDKit 2D
41 45 0 0 0 0 0 0 0 0999 V2000
35.4986 -4.5401 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
39.0380 -3.3141 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
39.0369 -4.1337 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.7449 -4.5426 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
39.7431 -2.9053 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.7407 -2.0881 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
40.4474 -1.6842 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.4470 -0.8706 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.7398 -0.4603 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
39.0315 -0.8698 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.0304 -1.6896 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.4518 -3.3105 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.4566 -4.1291 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.2372 -4.3772 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
41.7140 -3.7125 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
41.2288 -3.0531 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.6612 -5.0758 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.4782 -5.0579 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.9022 -5.7564 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.7192 -5.7385 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.1432 -6.4371 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.9602 -6.4192 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
45.3532 -5.7027 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
46.1702 -5.6848 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
44.9292 -5.0041 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
45.3221 -4.2876 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
38.3289 -4.5417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.6231 -4.1311 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.9155 -4.5385 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.9145 -5.3565 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.6268 -5.7655 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.3314 -5.3558 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.2070 -5.7655 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.4990 -5.3573 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.7916 -5.7663 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.0860 -5.3532 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.3806 -5.7587 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.3769 -6.5762 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
34.0846 -6.9866 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.7962 -6.5795 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.6743 -5.3478 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34 1 2 0
2 3 2 0
3 4 1 0
4 13 2 0
12 5 2 0
5 2 1 0
5 6 1 0
6 7 1 0
6 11 1 0
7 8 1 0
8 9 1 0
9 10 1 0
10 11 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 2 0
16 12 1 0
14 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
22 23 1 0
23 24 2 0
23 25 1 0
25 26 1 0
3 27 1 0
27 28 2 0
28 29 1 0
29 30 2 0
30 31 1 0
31 32 2 0
32 27 1 0
30 33 1 0
33 34 1 0
34 35 1 0
35 36 1 0
35 40 1 0
36 37 1 0
37 38 1 0
38 39 1 0
39 40 1 0
37 41 1 6
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 566.66Molecular Weight (Monoisotopic): 566.2965AlogP: 3.04#Rotatable Bonds: 10Polar Surface Area: 146.97Molecular Species: NEUTRALHBA: 10HBD: 3#RO5 Violations: 1HBA (Lipinski): 13HBD (Lipinski): 3#RO5 Violations (Lipinski): 2CX Acidic pKa: 8.91CX Basic pKa: 3.71CX LogP: 2.71CX LogD: 2.69Aromatic Rings: 3Heavy Atoms: 41QED Weighted: 0.19Np Likeness Score: -1.97
References 1. Chen Y, Yuan X, Zhang W, Tang M, Zheng L, Wang F, Yan W, Yang S, Wei Y, He J, Chen L.. (2019) Discovery of Novel Dual Histone Deacetylase and Mammalian Target of Rapamycin Target Inhibitors as a Promising Strategy for Cancer Therapy., 62 (3): [PMID:30629434 ] [10.1021/acs.jmedchem.8b01825 ]